Neuroone Medical Technologies (NMTC) Invested Capital (2010 - 2024)

Neuroone Medical Technologies (NMTC) has reported Invested Capital for 13 consecutive years, with $4.1 million the latest figure, recorded in Q1 2024.

• For the quarter ending Q1 2024, Invested Capital changed N/A year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2024 stood at $4.1 million (changed N/A YoY), and the FY2023 full-year result was $6.5 million, changed N/A from the prior year.
• Invested Capital retreated to $4.1 million in Q1 2024 per NMTC's latest filing, from $6.5 million in the prior quarter.
• Across five years, Invested Capital topped out at $6.5 million in Q3 2023 and bottomed at -$264107.0 in Q1 2020.
• Historically, Invested Capital has averaged $3.2 million across 3 years, with a median of $3.1 million in 2020.
• The widest YoY moves for Invested Capital: up 1000.06% in 2020, down 121.98% in 2020.
• Over 3 years, Invested Capital stood at $3.1 million in 2020, then jumped by 111.74% to $6.5 million in 2023, then plunged by 37.02% to $4.1 million in 2024.
• According to Business Quant data, Invested Capital over the past three periods registered $4.1 million, $6.5 million, and $3.1 million for Q1 2024, Q3 2023, and Q3 2020 respectively.